Heitz C, Descombes J J, Miller R C, Stoclet J C
Eur J Pharmacol. 1986 Apr 16;123(2):279-85. doi: 10.1016/0014-2999(86)90669-2.
The activity of the alpha-adrenoceptor antagonist nicergoline, a molecule composed of two constituent parts, ergoline and bromonicotinic acid, was investigated in the rat isolated aorta. Nicergoline (10 nM-0.1 microM) displaced concentration-effect curves elicited by noradrenaline and phenylephrine to the right and inhibited maximal responses elicited by both alpha-adrenoceptor agonists without significantly affecting prostaglandin F2 alpha-induced contractions. Higher concentrations of nicergoline (1 microM-50 microM) displaced to the right the concentration-effect curves elicited by calcium in a depolarizing medium. This calcium antagonist activity was not shared by either of the constituent parts. Nicergoline 100 microM abolished the 45Ca influx induced into rat aorta by 100 mM K+-containing physiological solution. The selectivity of nicergoline for alpha 1-adrenoceptors seen in binding experiments also depends on the presence of the bromonicotinic moiety of the molecule. It is concluded that nicergoline, but not its substituent parts, displays both alpha 1-adrenoceptor and calcium antagonism. The latter property may account for some of the observed effects of this compound.
在大鼠离体主动脉中研究了α-肾上腺素能受体拮抗剂尼麦角林(一种由麦角林和溴烟酸两个组成部分构成的分子)的活性。尼麦角林(10 nM - 0.1 μM)使去甲肾上腺素和去氧肾上腺素引发的浓度-效应曲线右移,并抑制两种α-肾上腺素能受体激动剂引发的最大反应,而对前列腺素F2α诱导的收缩无明显影响。更高浓度的尼麦角林(1 μM - 50 μM)使去极化介质中钙引发的浓度-效应曲线右移。这种钙拮抗剂活性在任何一个组成部分中均未出现。100 μM的尼麦角林消除了含100 mM K⁺的生理溶液诱导大鼠主动脉的⁴⁵Ca内流。在结合实验中观察到的尼麦角林对α1-肾上腺素能受体的选择性也取决于分子中溴烟酸部分的存在。得出的结论是,尼麦角林而非其取代部分表现出α1-肾上腺素能受体拮抗作用和钙拮抗作用。后一种特性可能解释了该化合物观察到的一些效应。